Home » Topics » BioWorld Science

BioWorld Science
RSS

U.S. patent coverage for Verex's controlled-release AZT product

Nov. 18, 1997

Schering-Plough obtains rights to Vasomax

Nov. 18, 1997

FDA clears first inhaled corticosteroid for young children with asthma

Nov. 18, 1997

Sano: Q3 and nine-month highlights

Nov. 18, 1997

International phase III trial of Maxamine in malignant melanoma

Nov. 18, 1997

Evidence that Theratope elicits an antitumor cellular immune response presented

Nov. 18, 1997

Bristol-Myers Squibb: Q3 1997 highlights

Nov. 18, 1997

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

Second-generation, highly selective COX-2 inhibitors developed at Merck

Nov. 18, 1997

LXR's patented drug screening technology yields two novel apoptosis-suppressing agents

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...